Results 101 to 110 of about 16,301 (208)
Development of an oral push–pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles
, 2015 Zongzhe Zhao, Chao Wu, Ying Zhao, Yanna Hao, Ying Liu, Wenming ZhaoPharmacy School, Liaoning Medical University, Jinzhou, Liaoning Province, People’s Republic of ChinaAbstract: In this study, mesoporous silica nanoparticles (MSNs) were used to ...
Liu Y +5 more
core
Fenofibrate and Insulin Resistance
, 2011 Both animal and human models suggest that fenofibrate, a medication widely prescribed to decrease triglycerides, also decreases insulin resistance. In the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) cohort, which included 780 individual who
Paeglow, Corrie E
core
Fenofibrate and left ventricle remodeling in volume overload
, 2012 Aims : Fenofibrate is a peroxisome proliferator-associated receptor alpha agonist (PPARα) used clinically for the management of dyslipidemia and is a myocardial fatty acid oxidation stimulator.
Roussel, Élise +4 more
core +1 more source
The role of fenofibrate in clinical practice.
, 2007 Clinical guidelines highlight the importance of dyslipidaemia management for reducing the risk of cardiovascular disease in patients with type 2 diabetes and metabolic syndrome.
Cusi K. +3 more
core +1 more source
Toxicology ReportsAtorvastatin and fenofibrate are well-known lipid-lowering drugs. Atorvastatin acts by reducing the production of cholesterol through the inhibition of the 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMG Co-A reductase) enzyme, whereas fenofibrate ...
Sanjib Ghosh +2 more
doaj +1 more source
PPAR Research, 2011 Peroxisome proliferator-activated receptor-alpha (PPAR-α) activation by fenofibrate reduces blood pressure and sodium retention during DOCA-salt hypertension. PPAR-α activation reduces the expression of inflammatory cytokines, such as interleukin-6 (IL-
Dexter L. Lee +4 more
doaj +1 more source
Short Reports - Fenofibrate-induced myopathy
, 2004 Fenofibrate induced myopathy is a rare adverse event. We present a case of muscle pain and quadriparesis following administration of 200mg of fenofibrate for 35 days. Patient gradually improved after stopping the drug.
Bhaskar Ghosh +4 more
core
Dose-dependent effects of fenofibrate and uridine.
, 2014 (A) CARS images of liver tissues of C57bl/6 mice treated with different fenofibrate dosages. (B) Quantitative analysis of liver lipid level using ImageJ-assisted analysis of CARS images.
Thuc T. Le (114801) +2 more
core +1 more source
Fenofibrate attenuates the massive inflammatory response seen in JEV infection.
, 2013 The inflammatory response to JEV challenge was attenuated by fenofibrate as depicted by significant reduction in mRNA expression (A) and protein levels (B) of cytokines (TNF-α, IL-6, IL-1β) and chemokine (MCP-1) compared to JEV alone.
Kanhaiya Lal Kumawat (102188) +3 more
core +1 more source
, 2015 Yan Zhang,1,2,* Sainan Li,1,* Lei He,1 Fan Wang,1 Kan Chen,1 Jingjing Li,1 Tong Liu,1 Yuanyuan Zheng,1 Jianrong Wang,1,3 Wenxia Lu,1,3 Yuqing Zhou,1,4 Qin Yin,1,4 Yujing Xia,1 Yingqun Zhou,1 Jie Lu,1 Chuanyong Guo1 1Department of Gastroenterology ...
Xia Y +14 more
core